Apolipoprotein D expression in substantia nigra of Parkinson disease

Histology and Histopathology

Volumn 21, Issue 4-6, 2006, Pages 361-366

  Ordonez C ^a   Navarro, A ^a   Perez, C ^a   Astudillo, A ^b   Martinez E ^a   Tolivia, Jorge ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Apo D; Dopaminergic neurons; Glial cells; Immunohistochemistry; Neuromelanin

Indexed keywords

APOLIPOPROTEIN D; ARACHIDONIC ACID; LIPID; LIPOCALIN; APOLIPOPROTEIN; BIOLOGICAL MARKER; DOPAMINE; FREE RADICAL; MELANIN; NEUROMELANIN;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; FEMALE; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE DEGENERATION; NERVOUS SYSTEM INJURY; NEUROPROTECTION; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; CHEMISTRY; GLIA; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY; PHYSIOLOGY;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS; APOLIPOPROTEINS D; BIOLOGICAL MARKERS; DOPAMINE; FEMALE; FREE RADICALS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANINS; MIDDLE AGED; NEURODEGENERATIVE DISEASES; NEUROGLIA; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 33644843629     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Belloir B., Kovari E., Surini-Demiri M. and Savioz A. (2001). Altered apolipoprotein D expression in the brain of patients with Alzheimer disease. J. Neurosci. Res. 64, 61-69.
2. Boyles J.K., Notterpek L.M. and Anderson L.J. (1990). Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E and apolipoprotein A-I. J. Biol. Chem. 265, 17805-17815.
3. Dawson T.M. and Dawson V.L. (2003). Molecular pathways of neurodegeneration in Parkinson's disease. Science 302, 819-822.
4. Desagher S., Glowinski J. and Premont J. (1996). Astrocytes protect neurons from hydrogen peroxide toxicity. J. Neurosci. 16, 2553-2562.
5. Dexter D.T., Sian J., Rose S., Hindmarsh J.G., Mann V.M., Cooper J.M., Wells F.R., Daniel S.E., Lees A.J., Schapira A.H., Jenner P. and Marsen C.D. (1994). Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann. Neurol. 35, 38-44.
6. Díez-Itza I., Vizoso F., Merino A., Sánchez L.M., Tolivia J., Fernández J., Ruibal A. and López-Otín C. (1994). Expression and prognostic significance of Apolipoprotein D in breast cancer. Am. J. Pathol. 144, 310-320.
7. Drayna D., Fielding C., McLean J., Baer B., Castro G., Chen E., Comstock L., Henzel W., Kohr W., Rhee L., Wion K. and Lawn R. (1986). Cloning and expression of human apolipoprotein D cDNA. J. Biol. Chem. 26,16535-16539.
8. Fahn S. and Cohen G. (1992). The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32, 804-812.
9. Franz G., Reindi M., Patel S.C., Beer R., Unterrichter I., Berger T., Schmutzhard E., Poewe W. and Kampfl A. (1999). Increased expression of apolipoprotein D following experimental traumatic brain injury. J. Neurochem. 73, 1615-1625.
10. Glöckner F. and Ohm T.G. (2003). Hippocampal apolipoprotein D level depends on Braak stage and APOE genotype. Neuroscience 122, 103-110.
11. Horrobin D.F. (1998). The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophrenia Res. 30, 193-208.
12. Horrobin D.F. and Bennett C.N. (1999). New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism. Prostaglandins Leukot. Essent. Fatty Acids 60,141-167.
13. Jenner P. and Olanow C.W. (1996). Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47, 161-170.
14. Jenner P. and Olanow C.W. (1998). Understanding cell death in Parkinson's disease. Ann. Neurol. 44, 72-84.
15. Kalman J., McConathy W., Araoz C., Kasa P. and Lacko A.G. (2000). Apolipoprotein D in aging brain and in Alzheimer's dementia. Neurol. Res. 22, 330-336.
16. Khan M.M., Parikh V.V. and Mahadik S.P. (2003). Antipsychotic drugs differentially modulate apolipoprotein D in rat brain. J. Neurochem. 86, 1089-1100.
17. Kramer B.C., Yabut J.A., Cheong J., Jnobaptiste R., Robakis T., Olanow C.W. and Mytilineou C. (2004). Toxicity of glutathione depletion in mesencephalic cultures: a role for arachidonic acid and its lipoxygenase metabolites. Eur. J. Neurosci. 19, 280-286.
18. Lang A.E. and Lozano A.M. (1998a). Parkinson's disease. First of two parts. N. Engl. J. Med. 339, 1044-1053.
19. Lang A.E. and Lozano A.M. (1998b). Parkinson's disease. Second of two parts. N. Engl. J. Med. 339, 1130-1143.
20. Lehr H., Mankoff D.A., Corwin D., Santeusanio G. and Gown A.M. (1997). Application of Photoshop based image analysis to quantification of hormone receptor expression in breast cancer. J. Histochem. Cytochem. 45, 1559-1565.
21. Li Y., Maher P. and Schubert D. (1997). A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19, 453-463.
22. Maker T.K., Nedergaard M., Preuss A., Gelbard A.S., Perumal A.S. and Cooper A.J. (1994). Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain. J. Neurochem. 62, 45-53.
23. Montpied P., de Bock F., Lerner-Natoli M., Bockaert J. and Rondouin G. (1999). Hippocampal alterations of apolipoprotein E and D mRNA levels in vivo and in vitro following kainate excitotoxicity. Epylepsy Res. 35, 135-46.
24. Morais-Cabral J.H., Atkins G.L., Sánchez L.M., López-Boado Y.S., López-Otín C. and Sawyer L. (1995). Arachidonic acid binds to apolipoprotein D: implications for the protein's function. FEBS Lett. 366, 53-56.
25. Mytilineou C., Kokotos-Leonardi E.T., Kramer B.C., Jamindar T. and Olanow C.W. (1999). Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures. J. Neurochem. 73, 112-119.
26. Mytilineou C., Kramer B.C. and Yabut, J.A. (2002). Glutathione depletion and oxidative stress. Parkinsonism Relat. Disord. 8, 385-387.
27. Navarro A., Tolivia J., Astudillo A. and del Valle E. (1998). Pattern of apolipoprotein D immunoreactivity in human brain. Neuros. Lett. 254, 17-20.
28. Navarro A., Tolivia J. and del Valle E. (2001). Immunohistochemical presence of apolipoprotein D in senile plaques. J. Histotechnol. 24, 45-48.
29. Navarro A., del Valle E., Astudillo A., González del Rey C. and Tolivia J. (2003). Immunohistochemical study of distribution of apolipoproteins E y D in human cerebral β-amyloid deposits. Exp. Neurol. 184, 697-704.
30. Navarro A., del Valle E. and Tolivia J. (2004). Differential expression of apolipoprotein D in human astroglial and oligodendroglial cells. J. Histochem. Cytochem. 52, 1031-1036.
31. Ong W.Y., He Y., Suresh S. and Patel S.C. (1997). Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus. Neuroscience 79, 359-367.
32. Parikh V., Khan M.M. and Mahadik S.P. (2003). Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J. Psychiatr. Res. 37, 43-51.
33. Patel S.C., Asotra K., Patel Y.C. McConathy W.J., Patel R.C. and Suresh S. (1995). Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D. Neuroreport 6, 653-657.
34. Rao A.V. and Balachandran B. (2002). Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr. Neurosci. 5, 291-309.
35. Rassart É., Bedirian A., Do Carmo S., Guinard O., Sirois J., Terrisse L. and Milne R. (2000). Apolipoprotein D. Biochim. Biophys. Acta 1482,185-198.
36. Sánchez D., Ganfornina M.D. and Martinez, S., (2002). Expression pattern of the lipocalin apolipoprotein D during mouse embryogenesis. Mech. Dev. 110, 225-229.
37. Spreyer P., Schaal H., Kuhn G., Rothe T., Unterbeck A., Olek K. and Muller H.W. (1990). Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve. EMBO J. 9, 2479-2484.
38. Suresh S., Yan Z., Patel S.C., Patel Y.C. and Patel S.C. (1998). Cellular cholesterol storage in the Niemann-Pick disease type C mouse is associated with increased expression and defective processing of apolipoprotein D. J. Neurochem. 70, 242-251.
39. Terrisse L., Poirier J., Bertrand P., Merched A., Visvikis S., Siest G., Milne R. and Rassart É. (1998). Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J. Neurochem. 71, 1643-1650.
40. Terrisse L., Séguin D., Bertrand P., Poirier J., Milne R. and Rassart É. (1999). Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion. Mol. Brain Res. 70, 26-35.
41. Thomas E.A., Danielson P.E., Nelson P.A., Pribyl T.M., Hilbush B.S., Hasel K.W. and Sutcliffe J.G. (2001a). Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy. J. Neurochem. 76, 789-796.
42. Thomas E.A., Dean B., Pavey G. and Sutcliffe J.G. (2001b). Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders. Proc. Natl. Acad. Sci. USA 98, 4066-4071.
43. Thomas E.A., Dean B., Scarr E., Copolov D. and Sutcliffe J.G. (2003a). Differences in neuroanatomical sites of apo D elevation discriminate between schizophrenia and bipolar disorder. Mol. Psychiatr. 8, 167-175.
44. Thomas E.A., George R.C. and Sutcliffe J.G. (2003b). Apolipoprotein D modulates arachidonic acid signaling in cultured cells: implications for psychiatric disorders. Prostaglandins Leukot. Essent. Fatty Acids 69, 421-427.
45. Tolivia J., Navarro A. and Tolivia D. (1994). Differential staining of nerve cells and fibers for sections of paraffin-embedded material in mammalian central nervous system. Histochemistry 102, 101-104.
46. Trieu W.N. and Uckum F.M. (2000). Apolipoprotein E and apolipoprotein D expression in a murine model of singlet oxygen-induced cerebral stroke. Biochem. Biophys. Res. Com. 268, 835-841.
47. del Valle E., Navarro A., Méndez E., Juárez A., Astudillo A. and Tolivia J. (2001). Could apolipoprotein D be a neuronal marker of necrobiosis?. J. Histotech. 24, 29-35.
48. del Valle E., Navarro A., Astudillo A. and Tolivia, J. (2003). Apolipoprotein D expression in human brain reactive astrocytes. J. Histochem. Cytochem. 51,1285-1290.
49. Youdim M.B. and Riederer P. (1997). Understanding Parkinson's disease. Sci. Am. 1, 38-45.